Efficacy and Safety APT-1011 in Adult Subjects With Eosinophilic Esophagitis (EoE) (FLUTE-2)

NCT04281108 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

143

Enrollment

INDUSTRY

Sponsor class

Conditions

Eosinophilic Esophagitis

Interventions

DRUG: APT-1011
DRUG: Placebo oral tablet
PROCEDURE: Esophagogastroduodenoscopy

Sponsor

Ellodi Pharmaceuticals, LP